Quanyuantang Partners with PICC and Munich Re to Launch 'Tang Tong Bao', China's First Diabetic Retinopathy Insurance Product

In an era when chronic diseases such as diabetes are increasingly becoming major “killers” of public health, establishing an effective chronic disease management model has become an urgent challenge for society as a whole.

VCBeat (WeChat ID: vcbeat) has learned that Quanyi Health, a subsidiary under the insurance division of QuanYuanTang, has recently partnered with domestic and international insurance giants PICC and Munich Re to jointly launch “Tang Tong Bao,” China’s first insurance product for diabetic retinopathy. Designed to provide comprehensive “diabetic retinopathy health” coverage for individuals with diabetes, this product marks another strategic upgrade in Quanyi Health’s focused efforts in the chronic disease management market for diabetes.

According to a World Health Organization report, chronic diseases, with diabetes as a representative example, have become the leading threat to global public health. The focus of diabetes prevention and treatment lies in preventing and managing the onset and progression of diabetic complications. Diabetic retinopathy (abbreviated as “DR”) is a series of typical pathological changes caused by damage to the retinal microvasculature due to diabetes. It is a chronic, progressive disease that impairs vision and can even lead to blindness, currently ranking as the primary cause of blindness among adults. Data show that China accounts for one-quarter of the global diabetic population. Based on an incidence rate of 27%, the number of patients with diabetic retinopathy in China is estimated to exceed 30 million.

“Tang Tong Bao” is an innovative chronic disease management program meticulously designed for individuals with diabetes. In terms of coverage, it differs from traditional insurance products by allowing diabetic patients to enroll while already diagnosed, provided they meet basic underwriting criteria. It covers individuals aged 30 to 65, with renewability up to age 75. From the perspective of diabetic retinopathy health management, the program aims to engage diabetic patients by subtly fostering long-term, rational self-management habits during medication use and diabetic retinopathy screening. This approach effectively helps prevent diabetic complications. By integrating various aspects—including medication, insurance enrollment, mobile healthcare, health management, claims processing, and policy renewal—it establishes a closed-loop system for diabetic retinopathy health management.

“The launch of the ‘Tang Tong Bao’ product has enabled individuals with diabetes to truly enjoy reliable insurance coverage,” stated a relevant executive from Quanyi Health. The company is actively promoting the integration of mobile healthcare and internet-based insurance, rolling out exclusive insurance products tailored for chronic disease management, such as “Tang Tong Bao.” This initiative ensures that many patients with chronic conditions are no longer “isolated” from health insurance; instead, leveraging internet technologies, they gain access to more comprehensive and diversified health management services, thereby alleviating their concerns.

Quanyi Health is a subsidiary under the insurance business segment of Quanyuantang. As a key component of Quanyuantang’s integrated industrial layout encompassing “pharmaceuticals, internet, and insurance,” Quanyi Health has long been committed to innovative health services for chronic disease management. By leveraging pharmaceutical benefit management (PBM) strategies, it breaks down consumption barriers among medical institutions, pharmaceutical companies and pharmacies, insurance companies, corporate clients, and end users, thereby creating new value for all partners. The launch of “Tang Tong Bao” serves as further evidence of Quanyi Health’s successful cross-industry collaboration with PICC (People’s Insurance Company of China) and Munich Re.

PICC Property and Casualty Company is the earliest established, largest, and most powerful property insurance company since the founding of New China. It is a leader in the domestic property insurance market, consistently ranking first in Asia and retaining its position as the world’s largest single-brand property and casualty insurer. For many years, the company has adhered to a market-oriented and customer-centric approach, building core competitive advantages and establishing an outstanding corporate brand image.

As one of the world’s largest reinsurers, Munich Re was founded in 1880 and is headquartered in Munich, Germany. It operates non-life and life insurance businesses in more than 150 countries worldwide and maintains over 60 branch offices. In 1997, Munich Re established representative offices in Beijing and Shanghai, respectively. In 2003, it became the first international reinsurer to be granted a national comprehensive business license by the China Insurance Regulatory Commission (CIRC).

“Tang Tong Bao” is not only a powerful tripartite alliance that has established a new benchmark model for the chronic disease management of diabetes, but also represents a transformation in the operational philosophy and methods of internet insurance.